TickerFacts.

NovaBridge Biosciences (NBP): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

27.24M CNY
Year ended 2022-12-31
46.43M CNY2019-12-31: 0 CNY2020-12-31: 0 CNY2021-12-31: 46.43M CNY2022-12-31: 27.24M CNY27.24M CNY
2019-12-31 Cost of Revenue (CNY) 2022-12-31
Period endedCost of RevenueChange YoYSource filing
2022-12-3127.24M CNY-41.3%2024-04-30, From 2022-01-01
2021-12-3146.43M CNYn/a2024-04-30, From 2021-01-01
2020-12-310 CNYn/a2022-04-29, From 2020-01-01
2019-12-310 CNYn/a2022-04-29, From 2019-01-01